On the same day, Robert J. Hombach of Seaport Therapeutics acquired 13,000 shares for $18.14 each, totaling $235,768. This transaction also marks Hombach’s first insider buy in the last twelve months. The stock is currently up about 3.1% on Wednesday, and Hombach is already seeing gains, with the shares reaching a high of $20.04—up approximately 10.5% from his purchase price.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.







